Creso Pharma Limited
Creso Pharma Limited (COPHF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cophf · pe ratio · data through Dec 31, 2023
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Creso Pharma Limited (COPHF) measures how much investors pay for each dollar of the company's trailing earnings. COPHF's current PE ratio of N/A is calculated by dividing its stock price of $0.12 by its TTM earnings per share of -$0.02.
Source: FMP · /ratios-ttm · /analyst-estimates · 2023-12-31
PE Ratio History
2016 – 2023 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Creso Pharma LimitedYou COPHF | $132M | N/A | — | -$0.02 |
 Ascentage Pharma Group International AAPGV | $127M | N/A | — | -$5.37 |
 Anteris Technologies Ltd AMEUF | $120M | N/A | — | -$6.09 |
 AnGes, Inc. AMGXF | $143M | N/A | — | -$14.45 |
 Cell MedX Corp. CMXC | $126M | N/A | — | -$0.03 |
 BioHarvest Sciences Inc. CNVCF | $109M | N/A | — | -$0.93 |
 China Medical & HealthCare Group Limited COLRF | $123M | 0.03x | — | $0.03 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2023-12-31Latest FY2023 | — | $0.00 | — | |
2022-12-31 FY2022 | — | $-0.02 | — | |
2021-12-31 FY2021 | — | $-0.03 | — | |
2020-12-31 FY2020 | — | $-0.10 | — | |
2019-12-31 FY2019 | — | $-0.12 | — | |
2018-12-31 FY2018 | — | $-0.15 | — | |
2017-12-31 FY2017 | — | $-0.18 | — | |
2016-12-31 FY2016 | — | $-0.14 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Creso Pharma Limited (COPHF) measures how much investors pay for each dollar of the company's trailing earnings. COPHF's current PE ratio of N/A is calculated by dividing its stock price of $0.12 by its TTM earnings per share of -$0.02.
Frequently asked questions
COPHF pe ratio · 6 questionsCOPHF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.12 and TTM EPS of -$0.02. Data sourced from Financial Modeling Prep via COPHF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Creso Pharma Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09